Article
Sodium Butyrate Attenuates Diabetic Kidney Disease Partially via Histone Butyrylation…
Mediators of Inflammation · 2022 · Tingting Zhou, author Huiwen Xu, author Xi Cheng, author Yanqiu He, author Qian Ren, author Dongzhe Li, author Yumei Xie, author Chenlin Gao, author Yuanyuan Zhang, author Xiaodong Sun, author Yong Xu, author Wei Huang, author Daniela Caccamo, Academic Editor
Key facts
| Title | Sodium Butyrate Attenuates Diabetic Kidney Disease Partially via Histone Butyrylation Modification |
|---|---|
| First author | Tingting Zhou, author Huiwen Xu, author Xi Cheng, author Yanqiu He, author Qian Ren, author Dongzhe Li, author Yumei Xie, author Chenlin Gao, author Yuanyuan Zhang, author Xiaodong Sun, author Yong Xu, author Wei Huang, author Daniela Caccamo, Academic Editor |
| Journal | Mediators of Inflammation |
| Published | May 17, 2022 |
| DOI | 10.1155/2022/7643322 |
| Devices mentioned | K000364, K000365, K003846, K004010, K010362, K011738, K012324, K021513, K022171, K031755, K032552, K040796 and 22 more |
| Product codes mentioned | CEK, GIA, LBR, NBW, CGA, FPA, LFR, LZG, MRZ, NDC |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1